FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2089492050> ?p ?o ?g. }

• W2089492050 endingPage "23596" @default.
• W2089492050 startingPage "23581" @default.
• W2089492050 abstract "Idiopathic pulmonary fibrosis (IPF) is a chronic devastating disease with poor prognosis. Multiple pathological processes, including inflammation, epithelial mesenchymal transition (EMT), apoptosis, and oxidative stress, are involved in the pathogenesis of IPF. Recent findings suggested that nuclear factor-κB (NF-κB) is constitutively activated in IPF and acts as a central regulator in the pathogenesis of IPF. The aim of our study was to reveal the value of andrographolide on bleomycin-induced inflammation and fibrosis in mice. The indicated dosages of andrographolide were administered in mice with bleomycin-induced pulmonary fibrosis. On day 21, cell counts of total cells, macrophages, neutrophils and lymphocytes, alone with TNF-α in bronchoalveolar lavage fluid (BALF) were measured. HE staining and Masson’s trichrome (MT) staining were used to observe the histological alterations of lungs. The Ashcroft score and hydroxyproline content of lungs were also measured. TGF-β1 and α-SMA mRNA and protein were analyzed. Activation of NF-κB was determined by western blotting and electrophoretic mobility shift assay (EMSA). On day 21 after bleomycin stimulation, andrographolide dose-dependently inhibited the inflammatory cells and TNF-α in BALF. Meanwhile, our data demonstrated that the Ashcroft score and hydroxyproline content of the bleomycin-stimulated lung were reduced by andrographolide administration. Furthermore, andrographloide suppressed TGF-β1 and α-SMA mRNA and protein expression in bleomycin-induced pulmonary fibrosis. Meanwhile, andrographolide significantly dose-dependently inhibited the ratio of phospho-NF-κB p65/total NF-κB p65 and NF-κB p65 DNA binding activities. Our findings indicate that andrographolide compromised bleomycin-induced pulmonary inflammation and fibrosis possibly through inactivation of NF-κB. Andrographolide holds promise as a novel drug to treat the devastating disease of pulmonary fibrosis." @default.
• W2089492050 created "2016-06-24" @default.
• W2089492050 creator A5006876375 @default.
• W2089492050 creator A5027301633 @default.
• W2089492050 creator A5056556060 @default.
• W2089492050 creator A5064066871 @default.
• W2089492050 creator A5069316485 @default.
• W2089492050 date "2013-12-03" @default.
• W2089492050 modified "2023-10-09" @default.
• W2089492050 title "Protective Role of Andrographolide in Bleomycin-Induced Pulmonary Fibrosis in Mice" @default.
• W2089492050 cites W1498451757 @default.
• W2089492050 cites W1963967314 @default.
• W2089492050 cites W1965635977 @default.
• W2089492050 cites W1975393873 @default.
• W2089492050 cites W1986549410 @default.
• W2089492050 cites W1987818432 @default.
• W2089492050 cites W1990609181 @default.
• W2089492050 cites W1991057737 @default.
• W2089492050 cites W1994839187 @default.
• W2089492050 cites W1997359763 @default.
• W2089492050 cites W2001107394 @default.
• W2089492050 cites W2005333626 @default.
• W2089492050 cites W2027691370 @default.
• W2089492050 cites W2029816217 @default.
• W2089492050 cites W2036902108 @default.
• W2089492050 cites W2037510579 @default.
• W2089492050 cites W2053695710 @default.
• W2089492050 cites W2063721674 @default.
• W2089492050 cites W2066214189 @default.
• W2089492050 cites W2092455796 @default.
• W2089492050 cites W2092973313 @default.
• W2089492050 cites W2093727067 @default.
• W2089492050 cites W2101900404 @default.
• W2089492050 cites W2109426473 @default.
• W2089492050 cites W2111256250 @default.
• W2089492050 cites W2112384772 @default.
• W2089492050 cites W2122083530 @default.
• W2089492050 cites W2125594840 @default.
• W2089492050 cites W2129620455 @default.
• W2089492050 cites W2139257509 @default.
• W2089492050 cites W2167383172 @default.
• W2089492050 cites W2170394618 @default.
• W2089492050 cites W2409976397 @default.
• W2089492050 doi "https://doi.org/10.3390/ijms141223581" @default.
• W2089492050 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3876064" @default.
• W2089492050 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24300094" @default.
• W2089492050 hasPublicationYear "2013" @default.
• W2089492050 type Work @default.
• W2089492050 sameAs 2089492050 @default.
• W2089492050 citedByCount "42" @default.
• W2089492050 countsByYear W20894920502012 @default.
• W2089492050 countsByYear W20894920502014 @default.
• W2089492050 countsByYear W20894920502015 @default.
• W2089492050 countsByYear W20894920502016 @default.
• W2089492050 countsByYear W20894920502017 @default.
• W2089492050 countsByYear W20894920502018 @default.
• W2089492050 countsByYear W20894920502019 @default.
• W2089492050 countsByYear W20894920502020 @default.
• W2089492050 countsByYear W20894920502021 @default.
• W2089492050 countsByYear W20894920502022 @default.
• W2089492050 crossrefType "journal-article" @default.
• W2089492050 hasAuthorship W2089492050A5006876375 @default.
• W2089492050 hasAuthorship W2089492050A5027301633 @default.
• W2089492050 hasAuthorship W2089492050A5056556060 @default.
• W2089492050 hasAuthorship W2089492050A5064066871 @default.
• W2089492050 hasAuthorship W2089492050A5069316485 @default.
• W2089492050 hasBestOaLocation W20894920501 @default.
• W2089492050 hasConcept C126322002 @default.
• W2089492050 hasConcept C134018914 @default.
• W2089492050 hasConcept C142724271 @default.
• W2089492050 hasConcept C203014093 @default.
• W2089492050 hasConcept C2776232574 @default.
• W2089492050 hasConcept C2776694085 @default.
• W2089492050 hasConcept C2776914184 @default.
• W2089492050 hasConcept C2777714996 @default.
• W2089492050 hasConcept C2777961210 @default.
• W2089492050 hasConcept C2778341716 @default.
• W2089492050 hasConcept C2779797417 @default.
• W2089492050 hasConcept C2780559512 @default.
• W2089492050 hasConcept C2781244666 @default.
• W2089492050 hasConcept C2781357234 @default.
• W2089492050 hasConcept C502942594 @default.
• W2089492050 hasConcept C71924100 @default.
• W2089492050 hasConcept C98274493 @default.
• W2089492050 hasConceptScore W2089492050C126322002 @default.
• W2089492050 hasConceptScore W2089492050C134018914 @default.
• W2089492050 hasConceptScore W2089492050C142724271 @default.
• W2089492050 hasConceptScore W2089492050C203014093 @default.
• W2089492050 hasConceptScore W2089492050C2776232574 @default.
• W2089492050 hasConceptScore W2089492050C2776694085 @default.
• W2089492050 hasConceptScore W2089492050C2776914184 @default.
• W2089492050 hasConceptScore W2089492050C2777714996 @default.
• W2089492050 hasConceptScore W2089492050C2777961210 @default.
• W2089492050 hasConceptScore W2089492050C2778341716 @default.
• W2089492050 hasConceptScore W2089492050C2779797417 @default.
• W2089492050 hasConceptScore W2089492050C2780559512 @default.
• W2089492050 hasConceptScore W2089492050C2781244666 @default.
• W2089492050 hasConceptScore W2089492050C2781357234 @default.

• next